ImmuneRACE - Immune Response Action to COVID-19 Events

PURPOSE Aim 1. Compare disease-specific TCR signatures in patients vs. controls Aim 2. Identify antigens that elicit a T-cell response Aim 3. Risk Stratification based on immune signature Aim 4. Early detection Secondary Aim: Aim 5. Identify and/or confirm antigenic binding (BCR PairSEQ/neutralizing antibodies) STUDY POPULATION Approximately 1000 individuals, between the ages of 18 - 89 Cohort 1. EXPOSED to someone with a confirmed diagnosis of COVID-19 Cohort 2. ACTIVE COVID-19 Individuals with a confirmed diagnosis of COVID-19: Clinical diagnosis made by a medical professional, or Positive laboratory test Cohort 3. RECOVERED from COVID-19 Individuals with a previously confirmed diagnosed and cleared from active infection by either: Testing negative on two consecutive swab tests, or Cleared by a healthcare professional, or Resolution of symptoms METHODS Decentralized study (visits occur at participant's houses) Utilizing remote phlebotomy to collect (1) whole blood, (2) serum, (3) nose or throat swab Collection of relevant metadata by electronic questionnaire Option for longitudinal collection of up to 4 additional blood draws and questionnaires